The ways in which TAMs support tumor development are also diverse, such as generation of an immunosuppressive TME by anti-inflammatory cytokines and programmed death-ligand 1 (PD-L1) expression [276, 277], extracellular matrix remodeling [278] and facilitation of the angiogenic switch for large tumor nodules [279]. This evidence concerns the gene CD274 and neoplasm.